
# Cancer Drug Antitrust Claims

Published at: **2019-11-06T08:23:33+00:00**

Author: **BRIEF**

Original: [Courthouse News Service](https://www.courthousenews.com/cancer-drug-antitrust-claims/)

NEW YORK – The Second Circuit ruled that a Russian pharmaceutical firm’s antitrust claims were barred by the Foreign Trade Antitrust Improvements Act, because the alleged price-fixing and kickbacks aimed at thwarting the firm’s U.S. launch of cancer-treatment drugs occurred in Russia. 

        Return To Top
      
Copyright © 2019 courthousenews.com
